These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3055098)

  • 1. [Macrophage-lymphocyte alveolitis in pulmonary sarcoidosis. The role of T-lymphocytes and alveolar macrophages in the pathogenesis and monitoring of this disease].
    Rossi GA; Vassalo F; Sacco O; Cerri E; Degl'Innocenti L
    Rev Mal Respir; 1988; 5(5):511-8. PubMed ID: 3055098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
    Hunninghake GW
    Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
    Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG
    J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of superoxide anion by alveolar macrophages in sarcoidosis: evidence for the activation of the oxygen metabolism in patients with high-intensity alveolitis.
    Cassatella MA; Berton G; Agostini C; Zambello R; Trentin L; Cipriani A; Semenzato G
    Immunology; 1989 Mar; 66(3):451-8. PubMed ID: 2539325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T lymphocyte subsets in alveolar lavage and peripheral blood in sarcoidosis and extrinsic allergic alveolitis].
    Desrues B; Delaval P; Genetet N; Kernec J; Pencolé C; Merdrignac G; Cornillet B; Genetet B
    Pathol Biol (Paris); 1987 Dec; 35(10):1301-8. PubMed ID: 2963992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.
    Venet A; Hance AJ; Saltini C; Robinson BW; Crystal RG
    J Clin Invest; 1985 Jan; 75(1):293-301. PubMed ID: 3871200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Latent alveolitis in systemic disease. The transition between the normal and the pathological].
    Wallaert B; Dugas M; Tonnel AB; Voisin C
    Rev Mal Respir; 1990; 7(1):17-25. PubMed ID: 2251429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
    Robinson BW; McLemore TL; Crystal RG
    J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic changes of alveolar macrophages in smoking sarcoidosis patients.
    Leuenberger P; Vonmoos S; Vejdovsky R
    Eur J Respir Dis Suppl; 1985; 139():72-5. PubMed ID: 2412876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biochemical aspects of sarcoidosis. With special reference to angiotensin-converting enzyme (ACE).
    Rømer FK
    Acta Med Scand Suppl; 1984; 690():3-96. PubMed ID: 6097101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value and indications for bronchoalveolar lavage combined with transbronchial lung biopsy].
    Popper H; Pongratz M
    Wien Klin Wochenschr; 1987 Dec; 99(24):848-55. PubMed ID: 3439184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alveolar T-cell subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment.
    Ceuppens JL; Lacquet LM; Mariën G; Demedts M; van den Eeckhout A; Stevens E
    Am Rev Respir Dis; 1984 Apr; 129(4):563-8. PubMed ID: 6231871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathogenesis of sarcoidosis: current practical knowledge].
    Müller-Quernheim J
    Z Gesamte Inn Med; 1990 Oct; 45(19):573-7. PubMed ID: 2151549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered immunological reactivity in alveolar macrophages from patients with sarcoidosis.
    Gallagher RB; Guckian M; van Breda A; Odlum C; Fitzgerald MX; Feighery C
    Eur Respir J; 1988 Feb; 1(2):153-60. PubMed ID: 2966072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alveolar macrophage in sarcoidosis.
    du Bois RM
    Sarcoidosis; 1990 Mar; 7(1):15-8. PubMed ID: 2189174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phenotype of T lymphocytes and macrophages obtained by broncho-alveolar lavage of human lung].
    Kochman S; Bernard J; Caulet T; Cazabat A; Lavaud F; Masure F
    C R Seances Acad Sci III; 1983; 297(13):593-5. PubMed ID: 6424881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis.
    Martinet Y; Pinkston P; Saltini C; Spurzem J; Müller-Quernheim J; Crystal RG
    Am Rev Respir Dis; 1988 Nov; 138(5):1242-8. PubMed ID: 3264483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte phenotypes in bronchoalveolar lavage and lung tissue in sarcoidosis and idiopathic pulmonary fibrosis.
    Paradis IL; Dauber JH; Rabin BS
    Am Rev Respir Dis; 1986 May; 133(5):855-60. PubMed ID: 3486613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenetic aspects of sarcoidosis. Importance of local complement synthesis in alveolar macrophages].
    Pettersen HB; Johnson E
    Tidsskr Nor Laegeforen; 1992 May; 112(12):1570-3. PubMed ID: 1615506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Properties of inflammatory cells in broncho-alveolar lavage in pulmonary fibrosis].
    Dayer JM
    Schweiz Med Wochenschr; 1986 Sep; 116(37):1245-9. PubMed ID: 3764395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.